GF Fund Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$362K Hold
2,542
– – ﹤0.01% 228
2026
Q2
$398K Hold
2,542
– – ﹤0.01% 225
2026
Q1
$388K Sell
2,542
-1,730
-40% -$265K 0.01% 238
2025
Q4
$589K Buy
4,272
+1,730
+68% +$227K 0.01% 217
2025
Q3
$326K Hold
2,542
– – 0.01% 246
2025
Q2
$308K Buy
+2,542
New +$287K 0.01% 289

Other funds holding NVS

GF Fund Management's NVS Position: Q3 2026 in Review

GF Fund Management held its Novartis (NVS) position steady in Q3 2026 at 2,542 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #228.

GF Fund Management first reported a position in NVS in Q2 2025 and has held it in 6 quarters since. The position peaked at $589K in Q4 2025. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • GF Fund Management held 2,542 shares of Novartis worth $362K as of Q3 2026.
  • GF Fund Management left its Novartis share count unchanged in Q3 2026.
  • Novartis made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #228 holding.
  • GF Fund Management first reported a position in Novartis in Q2 2025 and has held it in 6 quarters since.
  • GF Fund Management's Novartis position peaked at $589K in Q4 2025.
  • 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.